Humana - HUM Stock Forecast, Price & News

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Humana in the last twelve months. There are currently 3 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" HUM shares.
View HUM analyst ratings or view top-rated stocks.

14 equities research analysts have issued 12 month price targets for Humana's shares. Their HUM share price forecasts range from $415.00 to $650.00. On average, they expect the company's stock price to reach $579.00 in the next year. This suggests a possible upside of 7.0% from the stock's current price.
View analysts price targets for HUM or view top-rated stocks among Wall Street analysts.

Humana's stock was trading at $463.86 at the beginning of the year. Since then, HUM stock has increased by 16.6% and is now trading at $540.95.
View the best growth stocks for 2022 here.

Humana saw a increase in short interest during the month of October. As of October 15th, there was short interest totaling 1,900,000 shares, an increase of 6.7% from the September 30th total of 1,780,000 shares. Based on an average daily trading volume, of 840,900 shares, the short-interest ratio is currently 2.3 days. Approximately 1.5% of the company's shares are sold short.
View Humana's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 1st 2023.
View our HUM earnings forecast.

Humana Inc. (NYSE:HUM) announced its quarterly earnings data on Wednesday, November, 3rd. The insurance provider reported $4.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.61 by $0.22. The insurance provider had revenue of $20.70 billion for the quarter, compared to the consensus estimate of $20.91 billion. Humana had a net margin of 3.07% and a trailing twelve-month return on equity of 19.99%. The firm's revenue was up 3.1% on a year-over-year basis. During the same period in the prior year, the firm posted $3.08 earnings per share.
Read the conference call transcript.

Humana declared a quarterly dividend on Thursday, October 27th. Investors of record on Friday, December 30th will be given a dividend of $0.7875 per share on Friday, January 27th. This represents a $3.15 annualized dividend and a yield of 0.58%. The ex-dividend date is Thursday, December 29th.
Read our dividend analysis for HUM.

Humana (NYSE:HUM) pays an annual dividend of $3.15 per share and currently has a dividend yield of 0.59%. The company has been increasing its dividend for 10 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 14.29%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, HUM will have a dividend payout ratio of 11.26% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for HUM.

Humana issued an update on its FY 2025 earnings guidance on Wednesday, November, 9th. The company provided earnings per share guidance of $37.00-$37.00 for the period. The company issued revenue guidance of -.

1,597 employees have rated Humana Chief Executive Officer Bruce D. Broussard on Glassdoor.com. Bruce D. Broussard has an approval rating of 87% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Humana investors own include UnitedHealth Group (UNH), NVIDIA (NVDA), Walt Disney (DIS), Visa (V), Mastercard (MA), Alibaba Group (BABA), Boeing (BA), Salesforce (CRM), Johnson & Johnson (JNJ) and JPMorgan Chase & Co. (JPM).

Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."

Humana's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (8.83%), Price T Rowe Associates Inc. MD (5.36%), State Street Corp (4.43%), Bank of New York Mellon Corp (1.34%), Newport Trust Co (1.07%) and Dimensional Fund Advisors LP (0.89%). Insiders that own company stock include Bruce D Broussard, Christopher H Hunter, David A Jr/Ky Jones, David A Jr/Ky Jones, Elizabeth D Bierbower, James J /Ky Obrien, Jorge S Mesquita, Joseph C Ventura, Samir Deshpande, Susan M Diamond, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming.
View institutional ownership trends.

Shares of HUM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of HUM stock can currently be purchased for approximately $540.95.

Humana (NYSE:HUM) has a market capitalization of $68.48 billion and generates $83.06 billion in revenue each year. The insurance provider earns $2.93 billion in net income (profit) each year or $22.05 on an earnings per share basis.

The company employs 95,500 workers across the globe.

Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The official website for the company is www.humana.com. The insurance provider can be reached via phone at (502) 580-1000, via email at amysmith@humana.com, or via fax at 502-580-3639.